Perspective Therapeutics, Inc. - 10-Q Filing
Perspective Therapeutics filed its quarterly report for March 31, 2026, disclosing financial updates including retained earnings and additional paid-in capital changes as well as ongoing fair value measurements related to corporate debt securities, commercial paper, asset-backed securities, U.S. Treasury instruments, certificates of deposit, money market funds, and other investments.
Tickers: $CATX